HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Previous close
$4.80
Day range
$4.68 - $5.12
Year range
$1.50 - $5.39
Market cap
3.29B USD
Avg Volume
1.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 42.39M | 161.03% |
Net income | -43.47M | 91.98% |
Net profit margin | — | — |
Earnings per share | -0.05 | — |
EBITDA | -42.36M | -162.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 156.68M | -35.24% |
Total assets | 176.78M | -30.65% |
Total liabilities | 132.57M | 9.19% |
Total equity | 44.21M | — |
Shares outstanding | 701.98M | — |
Price to book | 80.00 | — |
Return on assets | -55.81% | — |
Return on capital | -62.79% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -43.47M | 91.98% |
Cash from operations | -30.13M | -129.49% |
Cash from investing | 19.87M | 103.08% |
Cash from financing | 485.00K | -99.39% |
Net change in cash | -9.81M | 98.30% |
Free cash flow | -19.89M | -106.91% |
About
Founded
2003
Website
Employees
105